Mark Bodenrader
CIK 1830371 · See Remarks · last filed 2024-08-05
Mark Bodenrader is a corporate insider who has filed 9 SEC Form 4 insider transactions across 2 companies since 2020. Across all open-market trades the lifetime net is −$389.2K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
9
-$389.2K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | See Remarks | 20,528 | $44.96 | $922.9K | -$389.2K | 6 | 2024-01-23 |
| Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | See Remarks | — | $18.07 | — | $0 | 2 | 2021-02-05 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-05 | — | Disp (D) | −17,724 | $0 | |
| 2024-01-23 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-12-21 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | +11,395 | -$326.8K | EDGAR |
| 2023-06-05 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Mixed | +2,838 | -$62.4K | EDGAR |
| 2023-02-08 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-11 | Cerevel Therapeutics Holdings, Inc. (CERE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-02-05 | Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-30 | Cerevel Therapeutics Holdings, Inc. (CEREW) Delisted | Grant (A) | — | $0 | EDGAR |